Free articles: Pharma & healthcate

• Clinical Trials in Russia:a market worth noticing in the coming years May 2008

  Some 38,000 patients participated in clinical trials in Russia in 2007. PMR expects continuing high interest among pharmaceutical companies and Contract Research Organisations (CROs) in conducting clinical trials in this area in the years 2008-2009.…

• Non-pharmacy OTC market: to lose momentum after 2009 April 2008

  In 2007 the Polish non-pharmacy market of OTC products, encompassing drugs and dietary supplements, was worth PLN 785m (€230m), posting growth of 15% relative to 2006. In our opinion between 2008 and 2010 the market will continue to expand at a double-digit pace. Yet, the post-2009 growth rate may weaken to around…

• Private healthcare providers have captured one-third of the Polish healthcare market April 2008

  In 2007 Poles spent PLN 23bn (€6.1bn) on healthcare services and products, i.e., 13% more than in 2006. Over half of that amount was expenditure on drugs and medical devices. Medical services consumed PLN 5bn (€1.3bn) from patients’ own pockets.…

• Polish medical devices market to expand 50% by 2010 February 2008

  In the near future, the medical devices market in Poland, today worth PLN 4bn (€1bn), will expand by over 12% a year to nearly PLN 6bn (€1.5bn) in 2010, according to PMR’s latest report “Medical devices market in Poland 2008”.…

• Consolidation moves eastwards January 2008

  While the merger of the Hungarian firm Gedeon Richter and Polish Polpharma, leading players on the pharmaceutical market in Central and Eastern Europe, demonstrates that the era of consolidation is not over yet, the focus is moving eastwards. The markets of Romania, Ukraine and Russia offer interesting opportunities.…

• Overall Performance Pharmaceutical Industry in 2006 December 2007

  Since the price was strictly cut and controlled by National Development and Reform Commission (NDRC) last year, and the coverage of pharmaceutical products affected by that had become much wider, a big question mark had been left on the industry profitability. Moreover, as rise of the anti-bribe action and the collapse…

• State refund policy undercutting growth on PolandOctober 2007

  In 2006 pharmacy sales of pharmaceuticals in Poland totalled PLN 20.4bn (€5.2bn), 7.9% more than in 2005. However, 2007 PMR expects market growth to weaken by around 2.5% to give final sales of PLN 21bn (€5.5bn). The more sober forecast is due to the state’s refund policy, which favours sales of cheaper medications,…

• Drug sales through retailers to rise by a fifth in 2007 October 2007

  In 2006 the non-pharmacy drug distribution market in Poland accounted for 11% of total OTC trade and was worth over PLN 400m. According to PMR, in 2007 the sales of drugs through retail outlets will increase by 22% to exceed PLN 500m.

• Russian OTC market to double in value by 2012 October 2007

  Over the last five years the Russian OTC market has expanded at an average pace of 25% per year. It will continue to grow rapidly in the coming years to double in value by 2012, powered by growing domestic demand for more expensive OTC drugs and consumer’s rising purchasing power.

• Polish OTC market: upbeat forecast for 2007 June 2007

  According to the latest report “OTC market in Poland”, compiled by PMR in partnership with PharmaExpert, Poland’s OTC pharmacy market was worth PLN 5.7bn (€1.5bn) at the end of 2006, thus growing in value by 4.4% relative to the preceding year. PMR expects the market for over-the-counter products…